What is BatchLine?
BatchLine specializes in providing BatchLine Lite MES, a digital manufacturing execution system designed for the pharmaceutical and other GxP regulated sectors. Their innovative solution simplifies and streamlines critical production, quality, and compliance processes. By significantly reducing batch review times and implementation efforts, BatchLine empowers companies in pharmaceuticals, medical devices, biotechnology, and cannabis to digitize operations and enhance adherence to stringent regulatory standards. The platform's modern user experience and robust integration capabilities are engineered to foster a more efficient and error-proof manufacturing environment.
How much funding has BatchLine raised?
BatchLine has raised a total of $639K across 1 funding round:
Private Equity
$639K
Private Equity (2026): $639K with participation from B-EN-G
Key Investors in BatchLine
B-EN-G
B-EN-G Thai, a subsidiary of Toyo Business Engineering Corporation, is a business engineering firm focused on Production and Cost Management solutions, including their "MCFrame" and "A.S.I.A." ERP systems. Their expertise aligns with BatchLine's focus on streamlining manufacturing operations.
What's next for BatchLine?
The recent major strategic investment signals a new phase of growth and development for BatchLine. This capital is expected to fuel further innovation in their digital manufacturing solutions, potentially expanding their market reach within the GxP regulated industries. Strategic deployment of these funds will likely focus on enhancing product capabilities, scaling operations, and solidifying their position as a leader in compliance-driven manufacturing technology. The company is poised to capitalize on the increasing demand for digitized and compliant production processes.
See full BatchLine company page
